Old Web
English
Sign In
Acemap
>
authorDetail
>
Lyka B. Kalyandrug
Lyka B. Kalyandrug
Immunology
Calicheamicin
Biology
Lymphoma
Cancer research
3
Papers
226
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (3)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
CD20-specific antibody-targeted chemotherapy of non-Hodgkin’s B-cell lymphoma using calicheamicin-conjugated rituximab
2007
Cancer Immunology, Immunotherapy
John F. DiJoseph
Maureen Dougher
Douglas Armellino
Lyka B. Kalyandrug
Arthur Kunz
Erwin R. Boghaert
Philip Ross Hamann
Nitin K. Damle
Show All
Source
Cite
Save
Citations (46)
Antitumor Efficacy of a Combination of CMC-544 (Inotuzumab Ozogamicin), a CD22-Targeted Cytotoxic Immunoconjugate of Calicheamicin, and Rituximab against Non-Hodgkin's B-Cell Lymphoma
2006
Clinical Cancer Research
John F. DiJoseph
Maureen Dougher
Lyka B. Kalyandrug
Douglas Armellino
Erwin R. Boghaert
Philip Ross Hamann
Justin K. Moran
Nitin K. Damle
Show All
Source
Cite
Save
Citations (124)
Antibody-Targeted Chemotherapy with the Calicheamicin Conjugate hu3S193-N-Acetyl γ Calicheamicin Dimethyl Hydrazide Targets Lewisy and Eliminates Lewisy-Positive Human Carcinoma Cells and Xenografts
2004
Clinical Cancer Research
Erwin R. Boghaert
Latha Sridharan
Douglas Armellino
Kiran Khandke
John F. DiJoseph
Arthur Kunz
Maureen Dougher
Fan Jiang
Lyka B. Kalyandrug
Philip Ross Hamann
Philip Frost
Nitin K. Damle
Show All
Source
Cite
Save
Citations (56)
1
map